Antibiotic Selection for Ureteral Stent Infection
First-Line Antibiotic Options
- The American Urological Association recommends a single dose of intravenous third-generation cephalosporin, such as ceftriaxone, or ampicillin/sulbactam as the first-line antibiotic therapy for patients with infected ureteral stents, with a decrease in serious post-procedural sepsis-related complications from 50% to 9% in high-risk patients 1
- Ampicillin/sulbactam is an effective alternative first-line option that provides similar coverage against expected uropathogens 1
- The American Urological Association strongly recommends antimicrobial prophylaxis for patients undergoing ureteral stent procedures 2, 3
Antibiotic Selection Based on Patient Risk Factors
- For high-risk patients, ciprofloxacin or trimethoprim-sulfamethoxazole prophylaxis is recommended, with consideration of targeted prophylactic approach based on urine culture obtained a few days before scheduled stent exchange 1
- For standard risk patients, a single oral or IV dose of an antibiotic that covers both gram-positive and gram-negative uropathogens is recommended, with oral ciprofloxacin showing similar efficacy to intravenous cefazolin in preventing UTI and sepsis 2, 3
Common Pathogens to Consider
- The most common pathogens in ureteral stent infections include Pseudomonas, Escherichia coli, Stenotrophomonas, Klebsiella, and Enterococcus species, with up to 50% of infections being polymicrobial or involving normal skin flora 1
- Bacterial biofilms can form on stents, making infections more resistant to treatment 4
Important Clinical Considerations
- If purulent urine is encountered during the procedure, abort the procedure, establish appropriate drainage, culture the purulent urine, and continue broad-spectrum antibiotics pending culture results, according to the American Urological Association guidelines 2
Special Situations
- For complicated UTIs with systemic symptoms, consider combination therapy with amoxicillin plus an aminoglycoside, a second-generation cephalosporin plus an aminoglycoside, or an intravenous third-generation cephalosporin, as recommended by the European Urology guidelines 5, 6
- Only use ciprofloxacin if local resistance rates are <10% and when the patient does not require hospitalization or has anaphylaxis to β-lactam antimicrobials, according to the European Urology guidelines 6
Duration of Treatment
- For infected ureteral stents, treatment duration should be 7-14 days, with 14 days recommended for men when prostatitis cannot be excluded, as suggested by the European Urology guidelines 6
Prevention of Recurrent Infections
- Periodically reassess the need for ureteral stents to determine whether removal is possible, as the main risk factor for infection is the length of time the device remains in place, according to the American Urological Association guidelines 1
- Maintain a clean exit site area with antiseptic use and regular dressing exchange, and consider using chlorhexidine-impregnated dressings and exchanging them weekly for patients with frequent exit site infections 1